Global Genomic and Proteomic Tool Supply, Demand and Key Producers, 2023-2029

Description

The global Genomic and Proteomic Tool market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Smart food logistics provider helps FMCG industries to maintain the quality of foods, such as fruits and vegetables, so that it does not spoil. Smart food logistics companies use wireless temperature sensors that help preserve frozen foods and provide multi-zone monitoring in refrigerated trucks and trailers.

This report studies the global Genomic and Proteomic Tool demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Genomic and Proteomic Tool, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genomic and Proteomic Tool that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Genomic and Proteomic Tool total market, 2018-2029, (USD Million)
Global Genomic and Proteomic Tool total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Genomic and Proteomic Tool total market, key domestic companies and share, (USD Million)
Global Genomic and Proteomic Tool revenue by player and market share 2018-2023, (USD Million)
Global Genomic and Proteomic Tool total market by Type, CAGR, 2018-2029, (USD Million)
Global Genomic and Proteomic Tool total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Genomic and Proteomic Tool market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 3billion, Inc., Bio-Rad Laboratories, Inc., Lucigen Corp., Macrogen, Inc., Abbott, Thermal Fisher Scientific, Inc., Bio-Synthesis, Inc., GE Healthcare and QIAGEN NV, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Genomic and Proteomic Tool market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Genomic and Proteomic Tool Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Genomic and Proteomic Tool Market, Segmentation by Type
    Genomics
    Proteomics

Global Genomic and Proteomic Tool Market, Segmentation by Application
    Research Labs and Institutes
    Drug Discovery
    Bioinformatics
    Others

Companies Profiled:
    3billion, Inc.
    Bio-Rad Laboratories, Inc.
    Lucigen Corp.
    Macrogen, Inc.
    Abbott
    Thermal Fisher Scientific, Inc.
    Bio-Synthesis, Inc.
    GE Healthcare
    QIAGEN NV
    Novogene Corp.
    Waters Corp.
    OriGene Technologies
    Takara Bio, Inc.
    Vela Diagnostics

Key Questions Answered
1. How big is the global Genomic and Proteomic Tool market?
2. What is the demand of the global Genomic and Proteomic Tool market?
3. What is the year over year growth of the global Genomic and Proteomic Tool market?
4. What is the total value of the global Genomic and Proteomic Tool market?
5. Who are the major players in the global Genomic and Proteomic Tool market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Genomic and Proteomic Tool Introduction
    1.2 World Genomic and Proteomic Tool Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Genomic and Proteomic Tool Total Market by Region (by Headquarter Location)
        1.3.1 World Genomic and Proteomic Tool Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Genomic and Proteomic Tool Market Size (2018-2029)
        1.3.3 China Genomic and Proteomic Tool Market Size (2018-2029)
        1.3.4 Europe Genomic and Proteomic Tool Market Size (2018-2029)
        1.3.5 Japan Genomic and Proteomic Tool Market Size (2018-2029)
        1.3.6 South Korea Genomic and Proteomic Tool Market Size (2018-2029)
        1.3.7 ASEAN Genomic and Proteomic Tool Market Size (2018-2029)
        1.3.8 India Genomic and Proteomic Tool Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Genomic and Proteomic Tool Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Genomic and Proteomic Tool Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Genomic and Proteomic Tool Consumption Value (2018-2029)
    2.2 World Genomic and Proteomic Tool Consumption Value by Region
        2.2.1 World Genomic and Proteomic Tool Consumption Value by Region (2018-2023)
        2.2.2 World Genomic and Proteomic Tool Consumption Value Forecast by Region (2024-2029)
    2.3 United States Genomic and Proteomic Tool Consumption Value (2018-2029)
    2.4 China Genomic and Proteomic Tool Consumption Value (2018-2029)
    2.5 Europe Genomic and Proteomic Tool Consumption Value (2018-2029)
    2.6 Japan Genomic and Proteomic Tool Consumption Value (2018-2029)
    2.7 South Korea Genomic and Proteomic Tool Consumption Value (2018-2029)
    2.8 ASEAN Genomic and Proteomic Tool Consumption Value (2018-2029)
    2.9 India Genomic and Proteomic Tool Consumption Value (2018-2029)

3 World Genomic and Proteomic Tool Companies Competitive Analysis
    3.1 World Genomic and Proteomic Tool Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Genomic and Proteomic Tool Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Genomic and Proteomic Tool in 2022
        3.2.3 Global Concentration Ratios (CR8) for Genomic and Proteomic Tool in 2022
    3.3 Genomic and Proteomic Tool Company Evaluation Quadrant
    3.4 Genomic and Proteomic Tool Market: Overall Company Footprint Analysis
        3.4.1 Genomic and Proteomic Tool Market: Region Footprint
        3.4.2 Genomic and Proteomic Tool Market: Company Product Type Footprint
        3.4.3 Genomic and Proteomic Tool Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Genomic and Proteomic Tool Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Genomic and Proteomic Tool Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Genomic and Proteomic Tool Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Genomic and Proteomic Tool Consumption Value Comparison
        4.2.1 United States VS China: Genomic and Proteomic Tool Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Genomic and Proteomic Tool Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Genomic and Proteomic Tool Companies and Market Share, 2018-2023
        4.3.1 United States Based Genomic and Proteomic Tool Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Genomic and Proteomic Tool Revenue, (2018-2023)
    4.4 China Based Companies Genomic and Proteomic Tool Revenue and Market Share, 2018-2023
        4.4.1 China Based Genomic and Proteomic Tool Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Genomic and Proteomic Tool Revenue, (2018-2023)
    4.5 Rest of World Based Genomic and Proteomic Tool Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Genomic and Proteomic Tool Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Genomic and Proteomic Tool Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Genomic and Proteomic Tool Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Genomics
        5.2.2 Proteomics
    5.3 Market Segment by Type
        5.3.1 World Genomic and Proteomic Tool Market Size by Type (2018-2023)
        5.3.2 World Genomic and Proteomic Tool Market Size by Type (2024-2029)
        5.3.3 World Genomic and Proteomic Tool Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Genomic and Proteomic Tool Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Research Labs and Institutes
        6.2.2 Drug Discovery
        6.2.3 Bioinformatics
        6.2.4 Others
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World Genomic and Proteomic Tool Market Size by Application (2018-2023)
        6.3.2 World Genomic and Proteomic Tool Market Size by Application (2024-2029)
        6.3.3 World Genomic and Proteomic Tool Market Size by Application (2018-2029)

7 Company Profiles
    7.1 3billion, Inc.
        7.1.1 3billion, Inc. Details
        7.1.2 3billion, Inc. Major Business
        7.1.3 3billion, Inc. Genomic and Proteomic Tool Product and Services
        7.1.4 3billion, Inc. Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 3billion, Inc. Recent Developments/Updates
        7.1.6 3billion, Inc. Competitive Strengths & Weaknesses
    7.2 Bio-Rad Laboratories, Inc.
        7.2.1 Bio-Rad Laboratories, Inc. Details
        7.2.2 Bio-Rad Laboratories, Inc. Major Business
        7.2.3 Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Product and Services
        7.2.4 Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
        7.2.6 Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
    7.3 Lucigen Corp.
        7.3.1 Lucigen Corp. Details
        7.3.2 Lucigen Corp. Major Business
        7.3.3 Lucigen Corp. Genomic and Proteomic Tool Product and Services
        7.3.4 Lucigen Corp. Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Lucigen Corp. Recent Developments/Updates
        7.3.6 Lucigen Corp. Competitive Strengths & Weaknesses
    7.4 Macrogen, Inc.
        7.4.1 Macrogen, Inc. Details
        7.4.2 Macrogen, Inc. Major Business
        7.4.3 Macrogen, Inc. Genomic and Proteomic Tool Product and Services
        7.4.4 Macrogen, Inc. Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Macrogen, Inc. Recent Developments/Updates
        7.4.6 Macrogen, Inc. Competitive Strengths & Weaknesses
    7.5 Abbott
        7.5.1 Abbott Details
        7.5.2 Abbott Major Business
        7.5.3 Abbott Genomic and Proteomic Tool Product and Services
        7.5.4 Abbott Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Abbott Recent Developments/Updates
        7.5.6 Abbott Competitive Strengths & Weaknesses
    7.6 Thermal Fisher Scientific, Inc.
        7.6.1 Thermal Fisher Scientific, Inc. Details
        7.6.2 Thermal Fisher Scientific, Inc. Major Business
        7.6.3 Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Product and Services
        7.6.4 Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Thermal Fisher Scientific, Inc. Recent Developments/Updates
        7.6.6 Thermal Fisher Scientific, Inc. Competitive Strengths & Weaknesses
    7.7 Bio-Synthesis, Inc.
        7.7.1 Bio-Synthesis, Inc. Details
        7.7.2 Bio-Synthesis, Inc. Major Business
        7.7.3 Bio-Synthesis, Inc. Genomic and Proteomic Tool Product and Services
        7.7.4 Bio-Synthesis, Inc. Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Bio-Synthesis, Inc. Recent Developments/Updates
        7.7.6 Bio-Synthesis, Inc. Competitive Strengths & Weaknesses
    7.8 GE Healthcare
        7.8.1 GE Healthcare Details
        7.8.2 GE Healthcare Major Business
        7.8.3 GE Healthcare Genomic and Proteomic Tool Product and Services
        7.8.4 GE Healthcare Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 GE Healthcare Recent Developments/Updates
        7.8.6 GE Healthcare Competitive Strengths & Weaknesses
    7.9 QIAGEN NV
        7.9.1 QIAGEN NV Details
        7.9.2 QIAGEN NV Major Business
        7.9.3 QIAGEN NV Genomic and Proteomic Tool Product and Services
        7.9.4 QIAGEN NV Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 QIAGEN NV Recent Developments/Updates
        7.9.6 QIAGEN NV Competitive Strengths & Weaknesses
    7.10 Novogene Corp.
        7.10.1 Novogene Corp. Details
        7.10.2 Novogene Corp. Major Business
        7.10.3 Novogene Corp. Genomic and Proteomic Tool Product and Services
        7.10.4 Novogene Corp. Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Novogene Corp. Recent Developments/Updates
        7.10.6 Novogene Corp. Competitive Strengths & Weaknesses
    7.11 Waters Corp.
        7.11.1 Waters Corp. Details
        7.11.2 Waters Corp. Major Business
        7.11.3 Waters Corp. Genomic and Proteomic Tool Product and Services
        7.11.4 Waters Corp. Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Waters Corp. Recent Developments/Updates
        7.11.6 Waters Corp. Competitive Strengths & Weaknesses
    7.12 OriGene Technologies
        7.12.1 OriGene Technologies Details
        7.12.2 OriGene Technologies Major Business
        7.12.3 OriGene Technologies Genomic and Proteomic Tool Product and Services
        7.12.4 OriGene Technologies Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 OriGene Technologies Recent Developments/Updates
        7.12.6 OriGene Technologies Competitive Strengths & Weaknesses
    7.13 Takara Bio, Inc.
        7.13.1 Takara Bio, Inc. Details
        7.13.2 Takara Bio, Inc. Major Business
        7.13.3 Takara Bio, Inc. Genomic and Proteomic Tool Product and Services
        7.13.4 Takara Bio, Inc. Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Takara Bio, Inc. Recent Developments/Updates
        7.13.6 Takara Bio, Inc. Competitive Strengths & Weaknesses
    7.14 Vela Diagnostics
        7.14.1 Vela Diagnostics Details
        7.14.2 Vela Diagnostics Major Business
        7.14.3 Vela Diagnostics Genomic and Proteomic Tool Product and Services
        7.14.4 Vela Diagnostics Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Vela Diagnostics Recent Developments/Updates
        7.14.6 Vela Diagnostics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Genomic and Proteomic Tool Industry Chain
    8.2 Genomic and Proteomic Tool Upstream Analysis
    8.3 Genomic and Proteomic Tool Midstream Analysis
    8.4 Genomic and Proteomic Tool Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Genomic and Proteomic Tool Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Genomic and Proteomic Tool Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Genomic and Proteomic Tool Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Genomic and Proteomic Tool Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Genomic and Proteomic Tool Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Genomic and Proteomic Tool Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Genomic and Proteomic Tool Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Genomic and Proteomic Tool Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Genomic and Proteomic Tool Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Genomic and Proteomic Tool Players in 2022
    Table 12. World Genomic and Proteomic Tool Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Genomic and Proteomic Tool Company Evaluation Quadrant
    Table 14. Head Office of Key Genomic and Proteomic Tool Player
    Table 15. Genomic and Proteomic Tool Market: Company Product Type Footprint
    Table 16. Genomic and Proteomic Tool Market: Company Product Application Footprint
    Table 17. Genomic and Proteomic Tool Mergers & Acquisitions Activity
    Table 18. United States VS China Genomic and Proteomic Tool Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Genomic and Proteomic Tool Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Genomic and Proteomic Tool Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Genomic and Proteomic Tool Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Genomic and Proteomic Tool Revenue Market Share (2018-2023)
    Table 23. China Based Genomic and Proteomic Tool Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Genomic and Proteomic Tool Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Genomic and Proteomic Tool Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Genomic and Proteomic Tool Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Genomic and Proteomic Tool Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Genomic and Proteomic Tool Revenue Market Share (2018-2023)
    Table 29. World Genomic and Proteomic Tool Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Genomic and Proteomic Tool Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Genomic and Proteomic Tool Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Genomic and Proteomic Tool Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Genomic and Proteomic Tool Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Genomic and Proteomic Tool Market Size by Application (2024-2029) & (USD Million)
    Table 35. 3billion, Inc. Basic Information, Area Served and Competitors
    Table 36. 3billion, Inc. Major Business
    Table 37. 3billion, Inc. Genomic and Proteomic Tool Product and Services
    Table 38. 3billion, Inc. Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. 3billion, Inc. Recent Developments/Updates
    Table 40. 3billion, Inc. Competitive Strengths & Weaknesses
    Table 41. Bio-Rad Laboratories, Inc. Basic Information, Area Served and Competitors
    Table 42. Bio-Rad Laboratories, Inc. Major Business
    Table 43. Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Product and Services
    Table 44. Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Bio-Rad Laboratories, Inc. Recent Developments/Updates
    Table 46. Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
    Table 47. Lucigen Corp. Basic Information, Area Served and Competitors
    Table 48. Lucigen Corp. Major Business
    Table 49. Lucigen Corp. Genomic and Proteomic Tool Product and Services
    Table 50. Lucigen Corp. Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Lucigen Corp. Recent Developments/Updates
    Table 52. Lucigen Corp. Competitive Strengths & Weaknesses
    Table 53. Macrogen, Inc. Basic Information, Area Served and Competitors
    Table 54. Macrogen, Inc. Major Business
    Table 55. Macrogen, Inc. Genomic and Proteomic Tool Product and Services
    Table 56. Macrogen, Inc. Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Macrogen, Inc. Recent Developments/Updates
    Table 58. Macrogen, Inc. Competitive Strengths & Weaknesses
    Table 59. Abbott Basic Information, Area Served and Competitors
    Table 60. Abbott Major Business
    Table 61. Abbott Genomic and Proteomic Tool Product and Services
    Table 62. Abbott Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Abbott Recent Developments/Updates
    Table 64. Abbott Competitive Strengths & Weaknesses
    Table 65. Thermal Fisher Scientific, Inc. Basic Information, Area Served and Competitors
    Table 66. Thermal Fisher Scientific, Inc. Major Business
    Table 67. Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Product and Services
    Table 68. Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Thermal Fisher Scientific, Inc. Recent Developments/Updates
    Table 70. Thermal Fisher Scientific, Inc. Competitive Strengths & Weaknesses
    Table 71. Bio-Synthesis, Inc. Basic Information, Area Served and Competitors
    Table 72. Bio-Synthesis, Inc. Major Business
    Table 73. Bio-Synthesis, Inc. Genomic and Proteomic Tool Product and Services
    Table 74. Bio-Synthesis, Inc. Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Bio-Synthesis, Inc. Recent Developments/Updates
    Table 76. Bio-Synthesis, Inc. Competitive Strengths & Weaknesses
    Table 77. GE Healthcare Basic Information, Area Served and Competitors
    Table 78. GE Healthcare Major Business
    Table 79. GE Healthcare Genomic and Proteomic Tool Product and Services
    Table 80. GE Healthcare Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. GE Healthcare Recent Developments/Updates
    Table 82. GE Healthcare Competitive Strengths & Weaknesses
    Table 83. QIAGEN NV Basic Information, Area Served and Competitors
    Table 84. QIAGEN NV Major Business
    Table 85. QIAGEN NV Genomic and Proteomic Tool Product and Services
    Table 86. QIAGEN NV Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. QIAGEN NV Recent Developments/Updates
    Table 88. QIAGEN NV Competitive Strengths & Weaknesses
    Table 89. Novogene Corp. Basic Information, Area Served and Competitors
    Table 90. Novogene Corp. Major Business
    Table 91. Novogene Corp. Genomic and Proteomic Tool Product and Services
    Table 92. Novogene Corp. Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Novogene Corp. Recent Developments/Updates
    Table 94. Novogene Corp. Competitive Strengths & Weaknesses
    Table 95. Waters Corp. Basic Information, Area Served and Competitors
    Table 96. Waters Corp. Major Business
    Table 97. Waters Corp. Genomic and Proteomic Tool Product and Services
    Table 98. Waters Corp. Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Waters Corp. Recent Developments/Updates
    Table 100. Waters Corp. Competitive Strengths & Weaknesses
    Table 101. OriGene Technologies Basic Information, Area Served and Competitors
    Table 102. OriGene Technologies Major Business
    Table 103. OriGene Technologies Genomic and Proteomic Tool Product and Services
    Table 104. OriGene Technologies Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. OriGene Technologies Recent Developments/Updates
    Table 106. OriGene Technologies Competitive Strengths & Weaknesses
    Table 107. Takara Bio, Inc. Basic Information, Area Served and Competitors
    Table 108. Takara Bio, Inc. Major Business
    Table 109. Takara Bio, Inc. Genomic and Proteomic Tool Product and Services
    Table 110. Takara Bio, Inc. Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Takara Bio, Inc. Recent Developments/Updates
    Table 112. Vela Diagnostics Basic Information, Area Served and Competitors
    Table 113. Vela Diagnostics Major Business
    Table 114. Vela Diagnostics Genomic and Proteomic Tool Product and Services
    Table 115. Vela Diagnostics Genomic and Proteomic Tool Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 116. Global Key Players of Genomic and Proteomic Tool Upstream (Raw Materials)
    Table 117. Genomic and Proteomic Tool Typical Customers
List of Figure
    Figure 1. Genomic and Proteomic Tool Picture
    Figure 2. World Genomic and Proteomic Tool Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Genomic and Proteomic Tool Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Genomic and Proteomic Tool Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Genomic and Proteomic Tool Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Genomic and Proteomic Tool Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Genomic and Proteomic Tool Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Genomic and Proteomic Tool Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Genomic and Proteomic Tool Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Genomic and Proteomic Tool Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Genomic and Proteomic Tool Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Genomic and Proteomic Tool Revenue (2018-2029) & (USD Million)
    Figure 13. Genomic and Proteomic Tool Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Genomic and Proteomic Tool Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Genomic and Proteomic Tool Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Genomic and Proteomic Tool Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Genomic and Proteomic Tool Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Genomic and Proteomic Tool Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Genomic and Proteomic Tool Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Genomic and Proteomic Tool Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Genomic and Proteomic Tool Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Genomic and Proteomic Tool Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Genomic and Proteomic Tool by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Genomic and Proteomic Tool Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Genomic and Proteomic Tool Markets in 2022
    Figure 27. United States VS China: Genomic and Proteomic Tool Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Genomic and Proteomic Tool Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Genomic and Proteomic Tool Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Genomic and Proteomic Tool Market Size Market Share by Type in 2022
    Figure 31. Genomics
    Figure 32. Proteomics
    Figure 33. World Genomic and Proteomic Tool Market Size Market Share by Type (2018-2029)
    Figure 34. World Genomic and Proteomic Tool Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Genomic and Proteomic Tool Market Size Market Share by Application in 2022
    Figure 36. Research Labs and Institutes
    Figure 37. Drug Discovery
    Figure 38. Bioinformatics
    Figure 39. Others
    Figure 40. Genomic and Proteomic Tool Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Companies Mentioned

3billion, Inc.
Bio-Rad Laboratories, Inc.
Lucigen Corp.
Macrogen, Inc.
Abbott
Thermal Fisher Scientific, Inc.
Bio-Synthesis, Inc.
GE Healthcare
QIAGEN NV
Novogene Corp.
Waters Corp.
OriGene Technologies
Takara Bio, Inc.
Vela Diagnostics